Efficacy of low-dose cisplatin-based chemo-irradiation in assessing hearing loss for locally advanced head and neck cancer.
Liao
Xin-Biao
XB
Yan
Sen-Xiang
SX
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000532:radiotherapy*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects*; D003131:Combined Modality Therapy; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D034381:Hearing Loss / Q000139:chemically induced / Q000175:diagnosis* / Q000209:etiology; D006801:Humans; D011832:Radiation Injuries / Q000175:diagnosis*
D000970:Antineoplastic Agents; D002945:Cisplatin